Lamotrigine-associated Stevens-Johnson syndrome after discontinuation of interferon, ribavirin, and filgrastim: a case report.
Matthews
Annette M
AM
Fireman
Marian
M
Hauser
Peter
P
D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000139:chemically induced / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D000077213:Lamotrigine; D008297:Male; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D014227:Triazines / Q000009:adverse effects*
D018692:Antimanic Agents; D002121:Calcium Channel Blockers; D011994:Recombinant Proteins; D014227:Triazines; D016179:Granulocyte Colony-Stimulating Factor; D012254:Ribavirin; D007372:Interferons; D000069585:Filgrastim; D000077213:Lamotrigine